Arcus Biosciences, Inc.RCUSNYSE
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-1675.00%
↓ 970% below average
Average (34q)
-156.47%
Historical baseline
Range
High:459.97%
Low:-3451.29%
Volatility
-2499.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -1675.00% |
| Q2 2025 | 93.44% |
| Q1 2025 | -18.45% |
| Q4 2024 | 1.90% |
| Q3 2024 | 0.94% |
| Q2 2024 | -562.50% |
| Q1 2024 | 82.42% |
| Q4 2023 | -13.75% |
| Q3 2023 | 3.61% |
| Q2 2023 | 3.49% |
| Q1 2023 | -15.53% |
| Q4 2022 | -6.34% |
| Q3 2022 | -1.45% |
| Q2 2022 | -2.99% |
| Q1 2022 | -123.82% |
| Q4 2021 | 459.97% |
| Q3 2021 | -2.63% |
| Q2 2021 | -4.66% |
| Q1 2021 | -39.87% |
| Q4 2020 | -3451.29% |
| Q3 2020 | 103.42% |
| Q2 2020 | -59.77% |
| Q1 2020 | -62.04% |
| Q4 2019 | 24.61% |
| Q3 2019 | 20.27% |
| Q2 2019 | -55.33% |
| Q1 2019 | -39.22% |
| Q4 2018 | -11.03% |
| Q3 2018 | 23.61% |
| Q2 2018 | -19.26% |
| Q1 2018 | 0.10% |
| Q4 2017 | 42.32% |
| Q3 2017 | -139.38% |
| Q2 2017 | -32.38% |
| Q1 2017 | 0.00% |